Published in J Clin Microbiol on May 01, 1998
Influenza C virus infection in children, Spain. Emerg Infect Dis (2006) 0.85
Detection of influenza C virus by a real-time RT-PCR assay. Influenza Other Respir Viruses (2013) 0.84
Isolation of influenza C virus from pigs and experimental infection of pigs with influenza C virus. J Gen Virol (1983) 1.81
Interspecies transmission of influenza C virus between humans and pigs. Virus Res (1997) 1.39
Frequent occurrence of genetic reassortment between influenza C virus strains in nature. J Gen Virol (1996) 1.38
A further note on 1233 influenza C virus. Arch Gesamte Virusforsch (1951) 1.30
Type C influenza virus. I. Studies of the virus and its distribution. J Lab Clin Med (1954) 1.23
Influenza C virus infection in France. J Infect (1992) 1.05
Production of common colds in human volunteers by influenza C virus. Br Med J (1968) 1.01
A highly cytopathogenic influenza C virus variant induces apoptosis in cell culture. J Gen Virol (1997) 0.88
Experimental infection with a persistent influenza C virus variant leads to prolonged genome detection in the chicken lung. Acta Virol (1996) 0.82
Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry (2001) 4.70
Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet (1982) 2.34
Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet (1990) 1.67
Interaction of trachoma elementary bodies with host cells. Isr J Med Sci (1969) 1.43
Rifampicin--a new antitrachoma drug. Nature (1969) 1.43
Hepatitis and jaundice associated with measles in young adults. An analysis of 65 cases. Arch Intern Med (1983) 1.30
Illness, cytokines, and depression. Ann N Y Acad Sci (2000) 1.27
Anti-trachoma activity of rifampicin and rifamycin SV derivatives. Nature (1970) 1.26
Extent of measles hepatitis in various ages. Hepatology (1988) 1.21
Cytokines, "depression due to a general medical condition," and antidepressant drugs. Adv Exp Med Biol (1999) 1.20
In vitro correlates of cell-mediated immunity in human tonsils after natural or induced Rubella virus infection. J Infect Dis (1975) 1.20
Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans. Infect Immun (1978) 1.18
Rifapicin inhibition of trachoma agent in vivo. Nature (1969) 1.18
Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant (1993) 1.17
Vaccination by non-parenteral routes: characteristics of immune response. Dev Biol Stand (1976) 1.09
Anti-poxvirus activity of rifampicin associated with hydrazone side chain. Nature (1970) 1.04
Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors. Cancer Gene Ther (2008) 0.99
Prevalence of antibodies to enteroviruses and varicella-zoster virus among residents and overseas volunteers at agricultural settlements in Israel. J Med Virol (1986) 0.97
Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine. J Med Virol (2000) 0.92
Increased (2'-5')-oligo-A synthetase activity in patients with prolonged illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet (1982) 0.92
Viral antibodies in agricultural populations exposed to aerosols from wastewater irrigation during a viral disease outbreak. Am J Epidemiol (1987) 0.92
Failure of influenza vaccination in the aged. J Med Virol (1988) 0.92
Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis J (1991) 0.92
Antibody response to influenza immunization in patients after heart transplantation. Vaccine (1997) 0.90
Acquisition of antibodies to various Coxsackie and Echo viruses and hepatitis A virus in agricultural communal settlements in Israel. J Med Virol (1984) 0.90
Implications of secretory immune system in viral infections. Adv Exp Med Biol (1974) 0.90
Cell-mediated immune response to mumps virus infection in man. J Immunol (1976) 0.90
Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants. Transl Psychiatry (2013) 0.89
An immunoperoxidase study of cytomegalovirus mononucleosis. Arch Pathol Lab Med (1982) 0.89
Local and humoral chlamydial antibodies in trachoma patients of different age groups. Invest Ophthalmol (1972) 0.88
HIV infection and AIDS in Jerusalem: a microcosm of illness in Israel. Isr J Med Sci (1996) 0.87
A sensitive plaque inhibition technique for assay of antibodies to influenza virus: use to detect previous antigenic priming with influenza viruses. J Virol Methods (1980) 0.87
Hemagglutinin of trachoma agent. Isr J Med Sci (1968) 0.87
Newcastle disease virus pathogenesis in the respiratory tract of local or systemic immunized chickens. Avian Dis (1976) 0.87
Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1. J Gen Virol (2001) 0.86
Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly. Vaccine (2000) 0.86
A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice. Vaccine (1999) 0.86
Detection of herpes simplex virus in gingival tissue. J Periodontol (1992) 0.86
Non-A, non-B hepatitis not following transfusion: a study of hospital patients in Jerusalem. Isr J Med Sci (1982) 0.86
Cranberry juice constituents affect influenza virus adhesion and infectivity. Antiviral Res (2005) 0.86
Immunologic response of chicks to inactivated Newcastle disease virus. Avian Dis (1973) 0.85
Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies. Clin Diagn Lab Immunol (2000) 0.85
Development and characteristics of in-vitro correlates of cellular immunity to rubella virus in the systemic and mucosal sites in guinea pigs. J Immunol (1974) 0.85
Congocidine and distamycin A, antipoxvirus antibiotics. Antimicrob Agents Chemother (1972) 0.85
Psychological variables as predictors of rubella antibody titers and fatigue--a prospective, double blind study. J Psychiatr Res (1999) 0.84
Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine. J Med Virol (2001) 0.83
Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine (1995) 0.83
Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells. J Cancer Res Clin Oncol (1996) 0.83
A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice. Vaccine (1999) 0.83
How to predict the immune status of poliovirus vaccinees? A comparison of virus neutralization at a very low serum dilution versus ELISA in a cohort of infants. Int J Epidemiol (1990) 0.82
Use of complementary and alternative medicine among cancer patients in Israel. Eur J Oncol Nurs (2005) 0.82
The effect of a mesogenic and a lentogenic Newcastle disease virus strain on Burkitt lymphoma Daudi cells. J Cancer Res Clin Oncol (1995) 0.81
Local immunologic response to immunization with inactivated Newcastle disease virus. J Immunol (1971) 0.81
Immunoperoxidase method of identification of Leishmania in routinely prepared histological sections. Virchows Arch A Pathol Anat Histopathol (1983) 0.80
Immunoadjuvant activity of interferon-gamma-liposomes co-administered with influenza vaccines. Biochim Biophys Acta (2001) 0.80
Cellular response in humans following vaccination with Gripax influenza virus. J Med Virol (1982) 0.80
Early acquisition of cytomegalovirus antibodies in communal settlements (kibbutzim) in Israel. Am J Epidemiol (1984) 0.80
Interleukin-7-enhanced cytotoxic T lymphocyte activity after viral infection in marrow transplanted mice. Bone Marrow Transplant (1997) 0.79
Antibodies to cytomegalo and Epstein-Barr viruses in human saliva and gingival fluid. New Microbiol (1998) 0.79
Cytokine-induced resistance to microbial infections in normal, immunosuppressed and bone marrow transplanted mice. Bone Marrow Transplant (1992) 0.79
Influence of socioeconomic status on behavioral, emotional and cognitive effects of rubella vaccination: a prospective, double blind study. Psychoneuroendocrinology (1998) 0.79
Immunologic and virologic aspects of secretory immune system in human respiratory tract. Dev Biol Stand (1975) 0.79
Host factors affecting the homologous and heterologous immune response of cattle to FMDV: genetic background, age, virus strains and route of administration. Vaccine (1998) 0.79
Fetal outcome following primary herpetic gingivostomatitis in early pregnancy. Morphological study and updated appraisal. Isr J Med Sci (1986) 0.78
Immunological response to herpes simplex virus in human gingival fluid. J Periodontol (1982) 0.78
Is herpes simplex virus associated with pulp/periapical inflammation? Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 0.78
Host defense mechanisms in viral respiratory infections. Pediatr Res (1977) 0.78
Immunologic aspect of tonsils. Ann Otol Rhinol Laryngol (1975) 0.78
Severe influenza infection in a chronic hepatitis C carrier: failure of protective serum HI antibodies after IM vaccination. J Clin Virol (2004) 0.78
Detection of human cytomegalovirus DNA in human tonsillar lymphocytes. J Med Virol (1987) 0.78
Intraventricular interferon treatment for subacute sclerosing panencephalitis. J Child Neurol (1989) 0.77
Post-influenzal psychiatric disorder in adolescents. Acta Psychiatr Scand (1988) 0.77
Homologous and heterologous antibody response of cattle and sheep after vaccination with foot and mouth disease and influenza viruses. Vaccine (1998) 0.77
Secretory Newcastle disease virus antibodies from chicken respiratory tract. J Immunol (1972) 0.77
Antibodies to polioviruses in an Israeli population and overseas volunteers. J Med Virol (1990) 0.77
Augmentation of tumor cell immunogenicity by viruses--an approach to specific immunotherapy of cancer. Nat Immun Cell Growth Regul (1990) 0.77
Cytomegalovirus infection and disease after T cell depleted allogeneic bone marrow transplantation for malignant hematologic diseases. Transplant Proc (1989) 0.77
Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts. Isr J Med Sci (1988) 0.76
The sulcular epithelium as a reservoir for herpes simplex virus in man. J Periodontol (1973) 0.76
Dehydroepiandrosterone enhances influenza immunization in aged mice. Ann N Y Acad Sci (1995) 0.76
Rotavirus infection and rotavirus serum antibody in a cohort of children from Gaza observed from birth to the age of one year. Int J Epidemiol (1990) 0.76
Oral cavity herpes simplex virus--a risk factor to dental personnel and patients. An overview. Isr J Dent Sci (1989) 0.76
A double-blind trial of a new inactivated, trivalent, intra-nasal anti-influenza vaccine in general practice: relationship between immunogenicity and respiratory morbidity over the winter of 1997-98. J Clin Virol (2001) 0.75
[Acute hemorrhagic conjunctivitis]. Harefuah (1983) 0.75
[Recommendations of the Hadassah University Hospital Committee for active immunization against hepatitis B virus infection]. Harefuah (1983) 0.75
[Isoenzyme CPK-MB in myocardial infarction]. Harefuah (1980) 0.75
Serological markers as an aid in the diagnosis of viral infections. Isr J Med Sci (1983) 0.75
[Interferon in immunosuppressed patients with disseminated herpes]. Harefuah (1981) 0.75
Clinical and serological response in humans following immunization with Gripax influenza vaccine. J Med Virol (1983) 0.75
Posttransfusion non-A, non-B hepatitis after cardiac surgery: a prospective study. Vox Sang (1983) 0.75